GlassScriptPhysician profile
John Keith Miller
NPI 1104910330
$2,020.26
in general payments reported to CMS, 2019-2025
38 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $331 · 2021: $207 · 2022: $262 · 2023: $319 · 2024: $375 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $360.30 | 2022-2025 | |
| Amarin Pharma, INC. | $227.06 | 2019-2020 | |
| Lilly USA, LLC | $202.89 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $104.76 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.61 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $77.59 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.99 | 2019-2023 | |
| Glaxosmithkline, LLC. | $65.93 | 2019-2024 | Arexvy, Shingrix |
| Astellas Pharma US INC | $59.58 | 2021-2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $52.90 | 2024-2025 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $50.99 | 2021-2024 | Gardasil 9, Proquad, Rotateq |
| Phathom Pharmaceuticals, INC. | $50.27 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $49.64 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.54 | 2020-2022 | |
| Corcept Therapeutics | $38.81 | 2024-2025 | Korlym |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.